Total
0
Shares
Medical Developments International (ASX:MVP) - Chairman, David Williams - The Market Herald
Chairman, David Williams
Sourced: Australian Financial Review
  • Medical solutions company Medical Developments International (MVP) is now allowed to sell its pain relief medication, Penthrox, in Hungary
  • Penthrox can be used for emergency relief of moderate to severe pain in adult patients with trauma and associated pain
  • While MVP's European decentralised procedure and national phase is now complete, the company said it is yet to achieve government reimbursement
  • Once Medical Developments receives government reimbursement for Penthrox, the product will be free for patients to purchase
  • This announcement follows approvals in Bosnia and Herzegovina, which were received earlier this month
  • Medical Developments is up 4.1 per cent on the market today, trading for $8.13 per share

Medical solutions company Medical Developments International (MVP) is now allowed to sell its pain relief medication, Penthrox, in Hungary.

Penthrox is a fast non-opioid pain relief medication for patients with trauma and those requiring medication to relieve pain for surgical procedures.

In Hungary, Penthrox can now be used for emergency relief of moderate to severe pain in adult patients with trauma and associated pain.

Whilst MVP's European decentralised procedure and national phase is now complete, the company said it is yet to achieve government reimbursement. However, sales can still be made to the private market.

This announcement follows approvals in Bosnia and Herzegovina, which were received earlier this month. Medical Developments says it is also currently waiting for approvals in Greece and Malta.

Medical Developments is up 4.10 per cent on the market today, trading for $8.13 per share at 1:30 pm AEST.


Subscribe


MVP by the numbers
More From The Market Herald
LBT Innovations (ASX:LBT) - CEO, Brent Barnes - The Market Herald

" LBT Innovations (ASX:LBT) signs agreement with leading EU medical distributor

Meditech company LBT Innovations (LBT) has signed a marketing agent agreement with Beckman Coulter for the marketing of the APAS Independence in Europe.
Fiji Kava (ASX:FIJ) - CEO & Founder, Zane Yoshida - The Market Herald

" Fiji Kava (ASX:FIJ) partners with PHAMA Plus Program

Fiji Kava (FIJ) has partnered with the Pacific Horticultural and Agricultural Market Access (PHAMA) Plus Program to strengthen kava export opportunities.
eSense Lab (ASX:ESE) - CEO, Itzik Mizrahi - The Market Herald

" eSense-Lab (ASX:ESE) lands $10M sales deal with States-based Blue Science

Terpene-based sanitiser developer eSense-Lab (ESE) has locked in a potential $10 million sales contract with United States-based Blue Science Solutions.
Allegra Orthopaedics (ASX:AMT) - CEO, Jenny Swain - The Market Herald

" Allegra Orthpaedics (ASX:AMT) soars 500pc after buying synthetic bone patents

Medical company Allegra Orthopaedics (AMT) topped the winner’s chart by quite some distance today after buying the patents for a synthetic bone substitute